Mitokinin
New York, US · Founded 2017 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
Mitokinin was founded in 2017 by Nicholas Hertz.
NH
Nicholas HertzFounder
DC
Doug CrawfordNamed on SEC filing
DD
Daniel de Roulet, Jr.Named on SEC filing
Board
JF
Johannes FruehaufBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$9.5M disclosed across 2 rounds · 2017–2018
▶$5MraisedNov 2018 · 3 investors · BiotechnologyRule 506(b)
▶$5MraisedNov 2018 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Douglas CrawfordDirector
- Peter ParkerDirector
- Nicholas HertzDirector
- Daniel de Roulet, Jr.Executive Officer, Director
- Offering amount
- $6M
- Amount sold
- $5M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$4.5MraisedSep 2017 · 5 investors · BiotechnologyRule 506(b)
▶$4.5MraisedSep 2017 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Doug CrawfordDirector
- Nicholas HertzDirector
- Daniel de Roulet, Jr.Executive Officer, Director
- Johannes FruehaufDirector
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Mitokinin?
- Mitokinin was founded by Nicholas Hertz in 2017.
- Who are Mitokinin's investors?
- Mitokinin's investors include Pfizer Venture Investments.
- How much funding has Mitokinin raised?
- Mitokinin has disclosed $9.5M raised across 2 rounds.
- Where is Mitokinin headquartered?
- Mitokinin is headquartered in New York, US.